Correction: Reducing the harms of xylazine: clinical approaches, research deficits, and public health context

Affiliations

¹ College of Pharmacy, The University of Texas at Austin, 2409 University Avenue, A1910, PHR 3.208J, Austin, TX, 78712, USA. claire.zagorski@austin.utexas.edu.
² HIV Prevention Research Division, Department of Psychiatry, School of Medicine, University of Pennsylvania, 3535 Market Street, Suite 4000, Philadelphia, PA, 19104, USA.
³ Narcomedia, Inc., Philadelphia, PA, USA.
⁴ National Survivors Union, 1116 Grove St, Greensboro, NC, 27403, USA.
⁵ Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, 135 Dauer Drive, Chapel Hill, NC, 27599, USA.
⁶ University of Pennsylvania School of Nursing, Fagin Hall, 418 Curie Blvd, Philadelphia, PA, 19104, USA.
⁷ Greater Lawrence Family Health Center, 34 Haverhill Street, Lawrence, MA, 01841, USA.
⁸ College of Pharmacy, The University of Texas at Austin, 2409 University Avenue, A1910, PHR 3.208J, Austin, TX, 78712, USA.
⁹ Department of Pharmacology, Bowles Center for Alcohol Studies, University of North Carolina, CB#7178, 104 Manning Road, Chapel Hill, NC, 2759, USA.
¹⁰ University of North Carolina, 725 MLK Jr. Blvd., CB 7505, Chapel Hill, NC, 27599, USA.

Published Erratum

Claire M Zagorski et al. Harm Reduct J. 2023.

. 2023 Nov 27;20(1):170.

doi: 10.1186/s12954-023-00903-w.

¹ College of Pharmacy, The University of Texas at Austin, 2409 University Avenue, A1910, PHR 3.208J, Austin, TX, 78712, USA. claire.zagorski@austin.utexas.edu.
² HIV Prevention Research Division, Department of Psychiatry, School of Medicine, University of Pennsylvania, 3535 Market Street, Suite 4000, Philadelphia, PA, 19104, USA.
³ Narcomedia, Inc., Philadelphia, PA, USA.
⁴ National Survivors Union, 1116 Grove St, Greensboro, NC, 27403, USA.
⁵ Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, 135 Dauer Drive, Chapel Hill, NC, 27599, USA.
⁶ University of Pennsylvania School of Nursing, Fagin Hall, 418 Curie Blvd, Philadelphia, PA, 19104, USA.
⁷ Greater Lawrence Family Health Center, 34 Haverhill Street, Lawrence, MA, 01841, USA.
⁸ College of Pharmacy, The University of Texas at Austin, 2409 University Avenue, A1910, PHR 3.208J, Austin, TX, 78712, USA.
⁹ Department of Pharmacology, Bowles Center for Alcohol Studies, University of North Carolina, CB#7178, 104 Manning Road, Chapel Hill, NC, 2759, USA.
¹⁰ University of North Carolina, 725 MLK Jr. Blvd., CB 7505, Chapel Hill, NC, 27599, USA.

No abstract available

Erratum for

Reducing the harms of xylazine: clinical approaches, research deficits, and public health context.
Zagorski CM, Hosey RA, Moraff C, Ferguson A, Figgatt M, Aronowitz S, Stahl NE, Hill LG, McElligott Z, Dasgupta N. Zagorski CM, et al. Harm Reduct J. 2023 Sep 30;20(1):141. doi: 10.1186/s12954-023-00879-7. Harm Reduct J. 2023. PMID: 37777769 Free PMC article. Review.

1. Zagorski CM, et al. Reducing the harms of xylazine: clinical approaches, research deficits, and public health context. Harm Reduct J. 2023;20:141. doi: 10.1186/s12954-023-00879-7. - DOI - PMC - PubMed